The first study evaluating gene and protein expression of the EFNB2 ligand and its EphB4 receptor in patients with ESCC showed correlations between high EFNB2 expression, advanced stage of the disease, and a worse prognosis (38). Here, EFNB2 is linked to esophageal squamous cell carcinoma.